Nailfold capillaroscopy changes in systemic lupus erythematosus: correlations with disease activity and autoantibody profile

Abstract

In systemic lupus erythematosus (SLE) nailfold capillaroscopy (NC) studies have described many different nonspecific patterns. We decided to evaluate NC changes in 44 SLE patients, comparing them with the main clinical, demographic and laboratory parameters, thus to define the real role for NC and its abnormalities in the management of this disease. Fifteen patients (34%) complained of Raynaud’s phenomenon; nine of them (20%) showed relevant capillaroscopic changes (capillaroscopic score >1). In details: three patients (6.8%) had loss of capillaries, while 18 (41%) had a capillary length variability, 16 (36.5%) showing shorter and two (4.5%) longer capillaries; tortuous, meandering, bizarre, ramified and/or bushy capillaries were found in 26 (59%), seven (16%), two (4.5%), three (7%) cases, respectively. An irregular distribution of the capillary array was present in six cases (14%) while microhaemorrhages were found in four cases (9%). 4 patients (9%) showed enlarged capillaries and changes of blood flow. A capillaroscopic score >1 was more frequently associated with higher ECLAM (P < 0.005) and SLEDAI (P < 0.01) activity scores, with the presence of anti-cardiolipin (P < 0.04) and anti-Sm (P < 0.04) antibodies, and also with the presence (P < 0.04) and higher titer (P < 0.001) of anti-dsDNA antibodies. No statistically significant correlation was found among the different capillaroscopy findings, age, disease duration, or treatment, nor with any clinical manifestation of the disease, such as cutaneous, renal or neurological. Our findings confirm the importance of the microvascular involvement in SLE. The NC abnormalities seem to be related to the disease activity and to the presence of many different antibodies, highly involved in the expression of SLE. NC proved to be an easy-to-perform noninvasive technique, able to achieve useful data to better evaluate such a pleomorphic disease as SLE.

Keywords

autoantibodies disease activity nailfold capillaroscopy systemic lupus erythematosus

Get full access to this article

View all access options for this article.

References

Redish W , Messina EJ , Hughes G , McEwen C. Capillaroscopic observations in rheumatic diseases . Ann Rheum Dis 1970; 29: 244-253 .

Studer A , Hunziker T , Lutolf O , Schmidl J , Chen D , Mahler F. Quantitative nailfold capillary microscopy in cutaneous and systemic lupus erythematosus and localized and systemic scleroderma . J Am Acad Dermatol 1991; 24: 941-945 .

Caspary L , Schemeese C , Schoetensack I et al. Alterations of the nailfold capillary morphology associated with Raynaud’s phenomenon in patients with systemic lupus erythematosus . J Rheumatolet 1991; 18: 559-566 .

Kenig JG , Maricq HR , Bole GG. Blind evaluation of the diagnostic specificity of nailfold capillary microscopy in the connective tissue diseases . Arthritis Rheum 1991; 24: 885-891 .

Bongard O , Bounameaux H , Miescher PA , De Moerloose P. Association of anticardiolipin antibodies and abnormal nailfold capillaroscopy in patients with systemic lupus erythematosus . Lupus 1995; 4: 142-144 .

Furtado RNV , Pucinelli MLC , Cristo VV , Andrade LEC , Sato EI. Scleroderma-like nailfold capillaroscopic abnormalities are associated with anti-U1-RNP antibodies and Raynaud’s phenomenon in SLE patients . Lupus 2002; 11: 35-41 .

Maricq HR , Leroy EC , D’Angelo WA et al. Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders . Arthritis Rheum 1980; 23: 183-188 .

Kabasakal Y , Elvins DM , Ring EFJ , McHugh NJ. Quantitative nailfold capillaroscopy findings in a population with connective tissue disease and in normal healthy controls . Ann Rheum Dis 1996; 55: 507-512 .

Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus . Arthritis Rheum 1997; 40: 1725-1725 .

10.

Vitali C , Bencivelli W , Isenberg DA et al. Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. II. Identification of the variables indicative of disease activity and their use in the development of an activity score. The European Consensus Study Group for Disease Activity in SLE . Clin Exp Rheumatol 1992; 10: 541-547 .

11.

Bombardier C , Gladman DD , Urowitz MB , Caron D , Chang CH. Commitee on Prognosis Studies in SLE: derivation of the SLEDAI. A disease activity index for lupus patients . Arthritis Rheum 1992; 35: 630-640 .

12.

Maricq HR. Widefield capillary microscopy: technique and rating scale for abnormalities seen in scleroderma and related disorders . Arthrits Rheum 1981; 24: 1159-1165 .

13.

Cutolo M , Sulli A , Pizzorni C , Accardo S. Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis . J Rheumatol 2000; 27: 155-160 .

14.

Lee P , Leung FYK , Alderdice C , Armstrong SK. Nailfold capillary microscopy in the connective tissue diseases: a semiquantitative assessment . J Rheumatology 1983; 10: 930-938 .

15.

Granier F , Vayssairat M , Priollet P , Housset E. Nailfold capillary microscopy in mixed connective tissue disease . Arthritis Rheum 1986; 29: 189-195 .

16.

Groen H , ter Borg EJ , Postma DS , Wouda AA , van der Mark TW , Kallenberg CG. Pulmonary function in systemic lupus erythematosus is related to distinct clinical, serologic, and nailfold capillary patterns . Am J Med 1992; 93: 619-627 .

17.

Pallis M , Hopkinson N , Powell R. Nailfold capillary density as a possible indicator of pulmonary capillary loss in systemic lupus erythematosus but not in mixed connective tissue disease . J Rheumatol 1991; 18: 1532-1536 .

18.

Pisetsky DS. Anti-DNA antibodies in systemic lupus erythematosus . Rheum Dis North Am 1992; 18: 437-454 .

19.

Baranda F. A. , Andrews B. S. , Davis J. S. , Taylor R. P. Autoantibodies to Sm in patients with SLE . Arthritis Rheum 1981; 24: 1236-1243 .